Atrial Fibrillation AF - Biotech, Pharma and Life Science Channel
PubMed Articles
Arrhythmias during and after zoledronic acid infusion patients with bone metastasis.
Zoledronic acid (ZA) is one of the important bisphosphonates which is widely used in bone metastatic cancer and osteoporotic patients. In a few studies, it has been reported that treatment with bispho...
Coronary artery fistulae are uncommon but may be haemodynamically significant, being an incidental finding in 0.1-0.2% of coronary angiograms. Even rarer is the association between fistulae and non-at...
This study sought to determine the risk of ischemic stroke (IS)/thromboembolism (TE) associated with renal impairment and its incremental predictive value over established risk stratification scores (...
Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.
Pharmacological treatment of atrial fibrillation in the context of heart failure poses numerous challenges. Management decisions are limited by contraindications to several drugs and the paucity of ro...
Giant right atrial thrombus in premature newborn.
Pediatric guidelines for treatment options of right atrial thrombosis in newborn are quite limited. Herein we present a case with giant atrial thrombosis resulting from umbilical venous catheter and i...
Propafenone Versus Vernakalant for Conversion of Recent-Onset Atrial Fibrillation.
INTRODUCTION: An oral loading dose of propafenone 600 mg is used in our center as in other places around the world for conversion of recent onset atrial fibrillation (AF) in patients without structura...
Femoral Venous Hemostasis in Children Using the Technique of "Figure-of-Eight" Sutures.
BACKGROUND: Structural heart interventions require the use of relatively large-diameter delivery sheaths or latex nylon net balloon catheters, which results in a relatively large-diameter venous punct...
A Kinetic Study of Amyloid Formation: Fibril Growth and Length Distributions.
We propose a kinetic model for the self-aggregation by amyloid proteins. By extending several well-known models for protein aggregation, the time evolution of aggregate concentrations containing r pro...
The HATCH and CHA2DS 2-VASc scores : Prognostic value in pulmonary vein isolation.
AIMS: The HATCH score describes the risk of paroxysmal atrial fibrillation (Afib) progression, while the CHA2DS2vasc score depicts the risk of thromboembolic events in patients with Afib. We hypothesi...
News Articles
Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification
Greenville, NC area oral surgery center has recently completed CPR training and re-certification for all staff members. Greenville, North Carolina (PRWEB) May 23, 2013 Greenville Oral & Maxillofa...
New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice
According to court documents, on March 5, 2013 a woman filed a lawsuit in Illinois Southern District Court alleging that her husband took Pradaxa and suffered massive brain bleeding that led to his de...
At HRS, Topera Topples Conventional Wisdom About Atrial Fibrillation
Topera Medical questions the assumptions underlying current therapies for atrial fibrillation. Sanjiv Narayan, MD, PhD, the electrophysiologist who founded Topera, has developed a means of identifying...
BERLIN -- (Marketwired) -- 05/23/13 -- BIOTRONIK, a leading manufacturer of innovative medical technology, announced today that enrollment has been completed for the highly anticipated IMPACT study....
PARIS and CAESAREA, Israel, May 22, 2013 /PRNewswire/ -- New clinical data presented from the DEFLECT-I study demonstrates that Keystone Heart's TriGuard™ Cerebral Protection Device re...
St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference
St. Jude Medical, Inc. (NYSE:STJ) will present at the 38th Annual Deutsche Bank Health Care Conference on Wednesday, May 29, in Boston. John Heinmiller, executive vice president,...
WAYNE, N.J., May 21, 2013 /PRNewswire/ -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has acquired LAAx Inc., a privately held company that ha...
ANDOVER, Mass., May 21, 2013 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that CX50 xMATRIX, the world's first portable ultrasound with Philips' industry leading Li...
The Firm is currently investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious internal bleeding, a potentially deadly Pradaxa side effect. New York, New York (PRWEB) May...
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
NATICK, Mass., May 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate at the annual EuroPCR Scientific Program May 21-24 in Paris. "We are pleased to p...
Events
None
Companies
St. Jude Medical, Inc. / AGA Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worl...
Founded in 1998, SurgiVision, Inc. is a leader in the emerging field of MRI-guided interventions, creating innovative platforms for performing the next generation of minimally inv...
Founded in 1998, MRI Interventions, Inc. is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Util...
Acutus Medical and Index Ventures
Acutus Medical is a medical technology company committed to developing an innovative breakthrough platform technology of safe, cost effective and clinically advanced tools for the...
Based in Eden Prairie, Minn., NeoChord is a privately held medical technology company focused on advancing the treatment of mitral regurgitation. The Company expects to commercial...
Based in Eden Prairie, Minn., NeoChord is a privately held medical technology company focused on advancing the treatment of mitral regurgitation. The Company received CE marking i...
ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered products designed to eliminate known safety issues associated with well...
St. Jude Medical is dedicated to making life better for cardiac, neurological, and chronic pain patients worldwide through excellence in medical device technology and services. The company has five ma...
nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris® Coagulation Syste...
Topera Medical (Topera, Inc.) is developing the proprietary FIRMap® System to assist electrophysiologists in the identification of the electrical source of cardiac arrhythmias....
Clinical Trials
Left Atrial Appendage Occlusion Study II
A pilot, multicentre randomized controlled study of surgical left atrial occlusion (LAA) in 50 patients with atrial fibrillation/flutter undergoing cardiac surgery requiring cardiopulmonar...
The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrill...
Antithrombotic Triple Therapy in Humans
Background:The acute coronary syndrome (ACS) is a complication of coronary artery disease (CAD) and associated with increased mortality. Dual antiplatelet therapy of acetylsalicylic acid (...
Atrial Pacing for Termination and Prevention of Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with substantial morbidity and mortality. Present treatment strategies are aimed at termination of AF an...
NAVISTAR® THERMOCOOL® Catheter for the Treatment of Atrial Fibrillation
This trial compares the safety and effectiveness of catheter ablation for PAF with antiarrhythmic drug therapy. The investigational catheter being studied is the NAVISTAR® THERMOCOOL® ir...
APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation
A suboptimal level of resynchronization (cardiac resynchronization therapy [CRT]) achieved in many patients with actual standards and techniques based on tissue-Doppler echocardiography co...
Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
Hypothesis: Blocking the angiotensin (AT) II type 1 receptor (Olmesartan) reduces the incidence of episodes of atrial fibrillation in patients with paroxysmal atrial fibrillation during 1...
This trial will include patients who have a heart condition called atrial fibrillation. Atrial fibrillation is an abnormal rhythm (irregular beat) in the heart. Patients with atrial fibri...
Atrial fibrillation (abnormal rhythm in the upper chamber of the heart) is a common supraventricular arrhythmia (a type of abnormal heart rhythm) for which antiarrhythmic therapy is often...
Effects of Left Atrial Appendage Occlusion
The proposed work seeks to further understand the effects of LAA occlusion on cardiac structure and function, and in homeostasis. Numerous studies have implicated the left atrial appendag...
Videos
Atrial Fibrillation Symptoms & Treatments
NorthShore University HealthSystem Cardiac Electrophysiologists Wes Fisher, M.D., Jose Nazari, M.D. and Alex Ro, M.D. discuss atrial fibrillation. Atrial fib...
Medical and Biotech [MESH] Definitions
Natriuretic Peptides
Peptides that regulate the WATER-ELECTROLYTE BALANCE in the body, also known as natriuretic peptide hormones. Several have been sequenced (ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C-TYPE NATRIURETIC PEPTIDE).
Defibrillators
Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia (TACHYCARDIA, VENTRICULAR) that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias (called synchronized defibrillation or CARDIOVERSION), using relatively low-level discharges synchronized to the patient's ECG waveform. (UMDNS, 2003)
Brugada Syndrome
An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.
Atrial Septum
The thin membrane-like muscular structure separating the right and the left upper chambers (HEART ATRIA) of a heart.
Foramen Ovale, Patent
A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.
